Arno Therapeutics, Inc — Form D

Arno Therapeutics, Inc of Flemington, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-30. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Arie S Belldegrun, M.D.DirectorSan Mateo, CA
William F Hamilton, Ph.D.DirectorFlemington, NJ
Tomer F KarivDirectorFlemington, NJ
Jay F MoorinDirectorFlemington, NJ
Yacov F ReizmanDirectorFlemington, NJ
Steven B RuchefskyDirectorFlemington, NJ
David M TanenDirectorNew York, NY
Alexander Zukiwski, M.D.DirectorFlemington, NJ
Stefan M Proniuk, Ph.D.Executive OfficerFlemington, NJ
Alexander Zukiwski, M.D.Executive OfficerFlemington, NJ
Randy H ThurmanDirectorIselin, NJ
David M TanenExecutive OfficerNew York, NY
Arie S BelldegrunDirectorNew York, NY
Alexander R Zukiwski, M.D.Executive OfficerFlemington, NJ
Scott L NavinsExecutive OfficerFlemington, NJ
Tomer L KarivDirectorFlemington, NJ
Yacov L ReizmanDirectorFlemington, NJ
Stefan L Proniuk, Ph.D.Executive OfficerFlemington, NJ
Glenn R MattesDirectorFlemington, NJ
Glenn R MattesExecutive OfficerFlemington, NJ
Peter M KashDirectorSan Mateo, CA
Joshua A KazamDirectorSan Mateo, CA
William F HamiltonDirectorRadnor, PA
Robert I FalkDirectorParsippany, NJ

Other filings by this issuer (4)

FiledFormOfferingSold
2013-11-13D$30.8M$30.8M
2012-12-06D/A$18.4M$11.1M
2012-12-05D$18.4M$11.1M
2010-09-23D$13.2M$8.4M

More